These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 11344842)
1. From 5 fluorouracil to the new oral fluoropyrimidines: a brief overview of four decades of clinical investigations. Sulkes A Isr Med Assoc J; 2001 Apr; 3(4):278-81. PubMed ID: 11344842 [No Abstract] [Full Text] [Related]
2. Substitution of oral fluoropyrimidines for infusional fluorouracil with radiotherapy: how much data do we need? Crane CH; Sargent DJ J Clin Oncol; 2004 Aug; 22(15):2978-81. PubMed ID: 15210736 [No Abstract] [Full Text] [Related]
3. Genetic variants influencing fluoropyrimidine based-therapy and available methods to detect them. Di Francia R; Cimino L; Berretta M Eur Rev Med Pharmacol Sci; 2012 Mar; 16(3):285-98. PubMed ID: 22530343 [TBL] [Abstract][Full Text] [Related]
4. Just when you thought the fluorouracil debate was over: S-1 and gastric cancer. Ilson D J Clin Oncol; 2005 Oct; 23(28):6826-8. PubMed ID: 16145059 [No Abstract] [Full Text] [Related]
5. Defining the optimal schedule of drug administration: art or science? Twelves CJ J Clin Oncol; 2008 Apr; 26(11):1781-2. PubMed ID: 18398142 [No Abstract] [Full Text] [Related]
6. [5-fluorouracil]. Aiba K Gan To Kagaku Ryoho; 2001 Oct; 28(10):1368-79. PubMed ID: 11681244 [TBL] [Abstract][Full Text] [Related]
7. [Adjuvant therapy for colon cancer]. Lordick F; Rosenberg R; Stein HJ; Peschel C; Siewert JR Dtsch Med Wochenschr; 2004 Oct; 129(44):2366-71. PubMed ID: 15497107 [No Abstract] [Full Text] [Related]
8. [Patient preference for oral chemotherapy]. Schöffski P Krankenpfl J; 2002; 40(1-2):40-1. PubMed ID: 12035416 [No Abstract] [Full Text] [Related]
11. Developing a patient pathway to deliver a new oral chemotherapy. Deery P; Faithfull S Prof Nurse; 2003 Oct; 19(2):102-6. PubMed ID: 14593785 [TBL] [Abstract][Full Text] [Related]
12. Pulse therapy with 5-FU in eradicating actinic keratoses with less than recommended dosage. Robins P J Drugs Dermatol; 2002 Jul; 1(1):25-30. PubMed ID: 12847751 [TBL] [Abstract][Full Text] [Related]
14. Continuous infusional 5-fluorouracil in breast cancer or the revival of an old drug? Smith IE Ann Oncol; 1996 Oct; 7(8):771-2. PubMed ID: 8922189 [No Abstract] [Full Text] [Related]
15. Recent advances in oral fluoropyrimidine therapies. Proceedings of a meeting. Chicago, Illinois, USA. July 11, 1998. Oncology (Williston Park); 1998 Oct; 12(10 Suppl 7):9-56. PubMed ID: 9830618 [No Abstract] [Full Text] [Related]
17. Prognostic value of 5-fluorouracil metabolic enzyme genes in Dukes' stage B and C colorectal cancer patients treated with oral 5-fluorouracil-based adjuvant chemotherapy. Yamada H; Iinuma H; Watanabe T Oncol Rep; 2008 Mar; 19(3):729-35. PubMed ID: 18288408 [TBL] [Abstract][Full Text] [Related]
18. Intralesional fluorouracil injection in infantile digital fibromatosis. Oh CK; Son HS; Kwon YW; Jang HS; Kwon KS Arch Dermatol; 2005 May; 141(5):549-50. PubMed ID: 15897374 [No Abstract] [Full Text] [Related]
19. [Antineoplastic activity of 5-fluorouracil upon transdermal adminstration using "Coletex" napkins]. Vartanian LP; Oltarzhevskaia ND; Vershinina SF; Gornaeva GF; Pustovalov IuI; Korovina MA Vopr Onkol; 2001; 47(4):472-4. PubMed ID: 11710293 [TBL] [Abstract][Full Text] [Related]
20. [Treatment with 5-fluorouracil: randomized study comparing an oral preparation with intravenous administration]. Veronesi A; Talamini R; Mauro Trovò G; Tirelli U; Galligioni E; Tumolo S; Grigoletto E Clin Ter; 1981 May; 97(4):389-93. PubMed ID: 7018819 [No Abstract] [Full Text] [Related] [Next] [New Search]